Pharmaceutical Representative Training

OCTOBER 9, 2024

Introduction Every sales professional has experienced deals collapsing at the last minute due to objections from prospects. In the competitive world of pharmaceutical sales, effectively handling customer objections is crucial for success. There are times when your prospect will have multiple objections at once.

Sales 52

Sales Pharma Pharmaceutical Sales Prospecting 52

Pharmaceutical Technology

NOVEMBER 30, 2022

In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021.

Medical 98

Medical Manufacturing Insurance Side effects 98

Pharmaceutical Technology

MAY 31, 2023

In January 2021, the US Food and Drug Administration (FDA) granted SNIPR001 a fast track designation. Subjects were dosed over seven days, and reportedly only experienced mild to moderate side effects with no withdrawals. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Food and Drug Administration 98

Food and Drug Administration Safety Side effects FDA 98

PM360

AUGUST 9, 2022

Indeed, in research from the 2021 PURE Report, 3 50% of the patients responding found the therapy discussion to be a highly stressful period in their treatment journey. Hospital Admissions Associated with Medication Non-Adherence: A Systematic Review of Prospective Observational Studies.” Start Patient Support Immediately.

Education 59

Education Side effects Physicians Patients 59

Pharmaceutical Representative Training

JANUARY 8, 2025

1] How can mastering pharmacology give sales reps a competitive advantage when meeting with prospective HCPs? The rep also elaborates on this concern with clinical trial results showing no significant side effects in older adults due to prolonged drug concentrations or toxicities. Pharma Sales Training. PRC Program Information.

Pharmacology 52

Pharmacology Pharma sales reps Sales Pharma 52

Pharmaceutical Technology

JANUARY 22, 2023

Santhera’s new therapy binds to the same receptors as corticosteroids, but modifies the downstream activities of the receptors, potentially avoiding the side effects seen with corticosteroids. 2021 was a year of continued innovation and change in the Biopharmaceutical industry. rises/second (SD 0.0628) in the placebo group.

FDA 126

FDA Safety Pharmaceutical Patients 126

PM360

AUGUST 26, 2024

Between 2015 and 2021, over a quarter of the drugs approved by the US Food and Drug Administration (FDA) were associated with specific biomarkers. As of 2021, 537 million adults were living with diabetes worldwide. During the period from 2008 through 2020, the number of precision medicines in the US increased from 5 to 285.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

Pharmaceutical Technology

JUNE 5, 2023

With a higher expression of PD-1 and VEGF in tumour tissue and the tumour microenvironment, Summit claims that ivonescimab can more effectively target tumour tissue to provide safer treatment with fewer side effects. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Side effects 52

Side effects Patients Leads Prospecting 52

Pharmaceutical Technology

MAY 31, 2023

The document would include the drug/biological product name, side effects, directions for use, safety information, and a concise summary of indications and uses. 2021 was a year of continued innovation and change in the Biopharmaceutical industry. Free Report How is the Biopharmaceutical industry evolving?

Prescription 52

Prescription FDA Food and Drug Administration Medical 52

Pharmaceutical Technology

MARCH 24, 2023

Fox says adjuvant protein subunit vaccines can be a safer approach compared to live attenuated virus vaccines as there is a minimized risk of developing side effects. 2021 was a year of continued innovation and change in the Biopharmaceutical industry. Free Report How is the Biopharmaceutical industry evolving?

Pharma 64

Pharma Side effects Marketing Biopharma 64

Nixon Gwilt Law

NOVEMBER 5, 2021

On November 2, 2021, the Centers for Medicare and Medicaid Services (“CMS”) finalized the Medicare Physician Fee Schedule for Calendar Year 2022 (the “Final 2022 MPFS” or the “Final Rule”). We predict that the PHE will be extended beyond 2021, and that remote direct supervision will be permissible until at least December 31, 2022.

Physicians 52

Physicians Professional Services Medical Side effects 52